Do serum progesterone levels on day of embryo transfer influence pregnancy outcomes in artificial frozen-thaw cycles?


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
May 2020
Historique:
received: 24 11 2019
accepted: 31 01 2020
pubmed: 12 2 2020
medline: 14 1 2021
entrez: 12 2 2020
Statut: ppublish

Résumé

The purpose of this study is to investigate whether progesterone (P4) levels on the day of frozen-thawed embryo transfer (FET) to a hormonally prepared endometrium correlate with pregnancy outcomes. This is a large retrospective cohort analysis comprising of N = 2010 FETs. In these cycles, P4 levels on the day of transfer were assessed in relation to pregnancy outcomes. A threshold of 10 ng/mL was used to simulate currently accepted levels for physiological corpus luteal function. Biochemical pregnancy, clinical pregnancy, and live birth rates were compared between those with P4 levels above and below this threshold. Analyses using transfer day P4 thresholds of 5 ng/mL and 20 ng/mL were then completed to see if these could create further prognostic power. When comparing FET outcomes in relation to P4 levels < 10 ng/mL and ≥ 10 ng/mL, we observed no differences in biochemical pregnancy rates (39.53% vs. 40.98%, p = 0.52), clinical pregnancy rates (20.82 vs. 22.78, p = 0.30), and live birth rates (14.25 vs. 16.21 p = 0.23). In patients whose P4 met the threshold of 20 ng/mL, there was similarly no statistically significant improvement in pregnancy outcomes. While there was no difference for biochemical or clinical pregnancy rates, a statistically significant improvement in live birth rates was observed for those with a transfer day P4 level ≥ 5 ng/mL. We demonstrated that P4 levels at or above 10 ng/mL on the day of FET do not confer a statistically significant improvement in pregnancy outcomes. P4 below 5 ng/mg was associated with lower live birth rates suggesting that there is a threshold below which it is difficult to salvage FET cycles.

Identifiants

pubmed: 32043182
doi: 10.1007/s10815-020-01713-w
pii: 10.1007/s10815-020-01713-w
pmc: PMC7244647
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1129-1135

Commentaires et corrections

Type : CommentIn

Références

Cedrin-Durnerin I, et al. Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium. Reprod BioMed Online. 2019;38(3):472–80.
doi: 10.1016/j.rbmo.2018.11.026 pubmed: 30642638
van der Linden M, et al. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;7.
Taraborrelli S. Physiology, production and action of progesterone. Acta Obstet Gynecol Scand. 2015;94:8–16.
doi: 10.1111/aogs.12771 pubmed: 26358238
Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril. 1994;62(3):485–90.
doi: 10.1016/S0015-0282(16)56935-0 pubmed: 8062942
Paulson RJ, Collins MG, Yankov VI. Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert. J Clin Endocrinol Metab. 2014;99(11):4241–9.
doi: 10.1210/jc.2013-3937 pubmed: 24606090
De Ziegler D, et al. The first uterine pass effect. Ann N Y Acad Sci. 1997;828:291–9.
doi: 10.1111/j.1749-6632.1997.tb48550.x pubmed: 9329850
Racca A, Santos-Ribeiro S, de Munck N, Mackens S, Drakopoulos P, Camus M, et al. Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality? Hum Reprod. 2018;33(5):860–8.
doi: 10.1093/humrep/dey031 pubmed: 29481670
Esteves SC, et al. Association between progesterone elevation on the day of human chronic gonadotropin trigger and pregnancy outcomes after fresh embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cycles. Front Endocrinol (Lausanne). 2018;9:201.
doi: 10.3389/fendo.2018.00201
Ibrahim Y, et al. Elevated progesterone and its impact on birth weight after fresh embryo transfers. J Assist Reprod Genet. 2017;34(6):759–64.
doi: 10.1007/s10815-017-0920-8 pubmed: 28417348 pmcid: 5445056
Lawrenz B, Fatemi HM. Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity. Reprod BioMed Online. 2017;34(4):422–8.
doi: 10.1016/j.rbmo.2017.01.011 pubmed: 28162937
Yovich JL, Conceicao JL, Stanger JD, Hinchliffe PM, Keane KN. Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement. Reprod BioMed Online. 2015;31(2):180–91.
doi: 10.1016/j.rbmo.2015.05.005 pubmed: 26099447
Solomon HF, Sneeringer RM, Penzias AS. Prediction of pregnancy outcome by serum progesterone level after assisted reproductive technology. Fertil and Steril. 2008;90:Supp 231.
doi: 10.1016/j.fertnstert.2008.07.561
Arce JC, Balen A, Platteau P, Pettersson G, Andersen AN. Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction. Reprod BioMed Online. 2011;22(5):449–56.
doi: 10.1016/j.rbmo.2011.01.006 pubmed: 21397560
Blakemore JK, Kofinas JD, McCulloh D, Grifo J. Serum progesterone trend after day of transfer predicts live birth in fresh IVF cycles. J Assist Reprod Genet. 2017;34(3):339–43.
doi: 10.1007/s10815-016-0859-1 pubmed: 28083776 pmcid: 5360684
Labarta E, et al. Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study. Hum Reprod. 2017;32(12):2437–42.
doi: 10.1093/humrep/dex316 pubmed: 29040638
Brady PC, Kaser DJ, Ginsburg ES, Ashby RK, Missmer SA, Correia KF, et al. Serum progesterone concentration on day of embryo transfer in donor oocyte cycles. J Assist Reprod Genet. 2014;31(5):569–75.
doi: 10.1007/s10815-014-0199-y pubmed: 24619510 pmcid: 4016380
Tihomirova T, et al. Measurement of serum progesterone levels on the day of embryo transfer is a useful tool in prediction of successful pregnancy. Annuaire de l'Afrique du Nord. 2018;103:53–9.
Kofinas JD, Blakemore J, McCulloh D, Grifo J. Serum progesterone levels greater than 20 ng/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates. J Assist Reprod Genet. 2015;32(9):1395–9.
doi: 10.1007/s10815-015-0546-7 pubmed: 26238390 pmcid: 4595397
Sifer C, et al. Outcome of embryo vitrification compared to slow freezing process at early cleavage stages. Report of the first French birth. Gynecol Obstet Fertil. 2012;40(3):158–61.
doi: 10.1016/j.gyobfe.2011.10.004 pubmed: 22154672
Gardner, D. and W. Schoolcraft, In vitro culture of human blastocyst, in Towards Reproductive Certainty: Fertility and Genetics Beyond 1999, J. R and M. D, Editors., Parthenon Publishing Carnforth: UK. 1999 p. 378–388.
Hull MG, Savage PE, Bromham DR, Ismail AA, Morris AF. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles. Fertil Steril. 1982;37(3):355–60.
doi: 10.1016/S0015-0282(16)46095-4 pubmed: 7060786
Jordan J, et al. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril. 1994;62(1):54–62.
doi: 10.1016/S0015-0282(16)56815-0 pubmed: 8005304
Kumar P, Magon N. Hormones in pregnancy. Niger Med J. 2012;53(4):179–83.
doi: 10.4103/0300-1652.107549 pubmed: 23661874 pmcid: 3640235
Spencer TE, Bazer FW. Biology of progesterone action during pregnancy recognition and maintenance of pregnancy. Front Biosci. 2002;7:d1879–98.
doi: 10.2741/spencer pubmed: 12161340
Bayard F, Louvet JP, Monrozies M, Boulard A, Pontonnier G. Endometrial progesterone concentrations during the menstrual cycle. J Clin Endocrinol Metab. 1975;41(2):412–4.
doi: 10.1210/jcem-41-2-412 pubmed: 1159054
Carson RL, Ganjam VK, Hudson RS, McLeod C, Kwapien R. Plasma and endometrial progesterone content following exogenous progesterone administration in mares. Theriogenology. 1983;19(2):235–41.
doi: 10.1016/0093-691X(83)90009-2 pubmed: 16725790
Cicinelli E, et al. Direct transport of progesterone from vagina to uterus. Obstet Gynecol. 2000;95(3):403–6.
pubmed: 10711552
Nahoul K, Dehennin L, Jondet M, Roger M. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas. 1993;16(3):185–202.
doi: 10.1016/0378-5122(93)90064-O pubmed: 8515718
Archer DF, et al. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Am J Obstet Gynecol. 1995;173(2):471–7 discussion 477–8.

Auteurs

Michelle Volovsky (M)

Maimonides Medical Center (OBGYN), New York, NY, USA. michelle.volovsky@gmail.com.
Royal Women's Hospital (OBGYN), Melbourne, VIC, Australia. michelle.volovsky@gmail.com.

Cassandra Pakes (C)

Royal Women's Hospital (OBGYN), Melbourne, VIC, Australia.

Genia Rozen (G)

Royal Women's Hospital (OBGYN), Melbourne, VIC, Australia.
Melbourne IVF, Melbourne, VIC, Australia.

Alex Polyakov (A)

Royal Women's Hospital (OBGYN), Melbourne, VIC, Australia.
Melbourne IVF, Melbourne, VIC, Australia.
University of Melbourne, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH